Diabetic Educators Seek Out Cell Robotics' Lasette at National Meeting in Florida.

ALBUQUERQUE, N.M.--(BW HealthWire)--August 24, 1999--

Cell Robotics International, Inc. (OTC: CRII), reported today that both the Professional and Personal Lasette(R) products were displayed in the Chronimed, Inc. (Nasdaq: CHMD) booth at the American Association of Diabetes Educators meeting held in Orlando, Florida, August, 19-21, 1999.

Mr. Travis Lee, vice president sales and marketing for Cell Robotics, commented, "At times there were educators waiting in line at all four testing stations to try the Lasette. Diabetes educators are very interested in minimizing the pain and soreness for their patients. Furthermore, their patients have been asking about the Lasette, so they wanted to try it. Most seem pleased with what they saw and the enthusiasm exceeded our expectations."

The American Association Diabetes Educators (AADE) represents 16,000 diabetic educators that train diabetics on how to treat their disease and monitor their progress. The members of the AADE are extremely important to the successful introduction of new technology. With over 10 million Americans and over 100 million people worldwide diagnosed with diabetes, the market potential for the Lasette is large. Chronimed Inc., is the exclusive worldwide distributor of Cell Robotics' Lasette.

Dr. Ronald K. Lohrding, Ph.D., chairman, president and chief executive officer of Cell Robotics, commented, "We are elated with the AADE reception of the Personal Lasette. Customer-suggested changes in the plastic parts and laser beam conditioning should complete the development stage. We are eager to initiate manufacturing, but will not until we have addressed all customer input and quality control issues. The Personal Lasette is a paradigm shift away from steel lancets in the treatment of diabetes and the product must be of the highest quality when introduced this fall."

The Lasette is the only laser-based home-use alternative to the stainless steel lancet that is cleared by the FDA for collecting blood samples to monitor glucose levels and is the first medical laser device ever cleared by the FDA for use in the home. The new Personal Lasette can be seen on Cell Robotics' updated web site at http://www.cellrobotics.com.

In addition to the Lasette, Cell Robotics manufactures, markets, and distributes the IVF Workstation and the Cell Robotics Workstation. Additional information on all three products is available on the Cell Robotics Web Site at http://www.cellrobotics.com, by e-mail at [e-mail], or by telephone at [phone].

As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the Company's ability to execute its service and product sales plans; and the risks described from time to time in the Company's Securities and Exchange Commission filings.